FDA advisory committee to discuss strain-specific COVID-19 vaccines

The FDA advisory committee is meeting today to discuss whether a strain-specific COVID-19 vaccine should be in the works and how soon it could made available to the public.

More Stories

00:48

Experts: Fiber has numerous benefits and should not be overlooked

00:25

Higher cases of RSV has led states to extend window for immunizations

02:19

Experts say upcoming tick season could be worse than last year

02:20

Experts say upcoming tick season could be worse than last year

00:26

Officials: Over 50% of ticks tested last year were positive for Lyme disease

01:41

Experts: Protein should be eaten during every meal